RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul Gottlieb to Adjuvants, Immunologic

Back to Details
This is a "connection" page, showing publications Paul Gottlieb has written about Adjuvants, Immunologic.
Paul Gottlieb
Connection Strength
0.031
Adjuvants, Immunologic
  1. Boigard H, Alimova A, Martin GR, Katz A, Gottlieb P, Galarza JM. Zika virus-like particle (VLP) based vaccine. PLoS Negl Trop Dis. 2017 May; 11(5):e0005608.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support